Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-30

Clinical Trial Update: Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin lispro vs insulin aspart in pump use completed; results posted in 2012 for Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin aspart (insulin aspart)
  • insulin lispro (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2012-10-30